Previous 10 | Next 10 |
Image source: The Motley Fool. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q3 2021 Earnings Call Nov 10, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2021 Earn...
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2021 Results Conference Call November 10, 2021 5:00 PM ET Company Participants Debra Hart - Senior Director, IR Carl Hull - CEO Kevin Herde - EVP, CFO Conference Call Participants Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Dan Arias ...
Maravai LifeSciences Holdings (NASDAQ:MRVI): Q3 GAAP EPS of $0.45 beats by $0.15. Revenue of $204.81M (+133.1% Y/Y) beats by $3.31M. Shares +6.99%. Press Release For further details see: Maravai LifeSciences Holdings EPS beats by $0.15, beats on revenue
SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2021,...
OTCQX:ACRGF, ADMA, AEVA, DADAAMPE, AMWL, APP, APPH, ASND, ATO, OTCPK:ATUSF, AZUL, BANX, BARK, BIOL, BKEP, BMBL, BOXL, BRFS, BRKS, BROS, BSQR, BW, BYND, BZH, CBAY, CCCS, CCMP, CGRN, CLSD, CLVR, CRCT, CYCC, DARE, DGII, DIS, EDRY, EGLX, ELMS, ENS, EVOK, FICO, FIGS, FOSL, FSM, GAU, GDRX, GEVO, OT...
New England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesis PR Newswire IPSWICH, Mass. , Nov. 8, 2021 /PRNewswire/ -- New England Bi...
The emerging dominance of COVID-19 pills and concerning outlook for vaccine makers dominated healthcare headlines this week amid a flurry of earnings reports. Yet, with an over twofold rise in value, a clinical-stage Alzheimer’s drug developer outshone them all. However, pressure on va...
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of November. ...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy generated positive absolute performance and ...
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2021 financial and operating results after the market clos...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...